SCHEMBL2861248

SCHEMBL2861248

C=C(C)CCCC(Oc1ccccc1)=C(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.35
PRSS1 P07477 1/20 0.35
PRSS2 P07478 1/20 0.35
PRSS3 P35030 1/20 0.35
PAX8 Q06710 1/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KCNA3 P22001 1/20 0.32
EGFR P00533 1/20 0.32
ERBB2 P04626 1/20 0.32
GPR174 Q9BXC1 1/20 0.32
HSP90AA1 P07900 1/20 0.31
GAA P10253 1/20 0.31
LMNA P02545 2/20 0.31
NPC1 O15118 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2864282 0.77 ALDH1A1 (0.47) ALDH1A1KMT2AL3MBTL1LMNATSHR
SCHEMBL29161879 0.76 PRSS1 (0.59) ELANEPRSS1PRSS2PRSS3ALDH1A1
SCHEMBL7428825 0.71 KCNA3 (0.59) ALDH1A1L3MBTL1KCNA3
SCHEMBL2872236 0.71 LMNA (0.34) ALDH1A1KMT2AL3MBTL1GAALMNA
SCHEMBL2868632 0.69 LSS (0.40) ALDH1A1MAPTL3MBTL1KCNA3GPR174
SCHEMBL2868634 0.69 LSS (0.40) ALDH1A1MAPTL3MBTL1KCNA3GPR174
SCHEMBL2860817 0.69 TSHR (0.33) TSHR
SCHEMBL1835409 0.68 KCNA3 (0.54) ALDH1A1MAPTKMT2AL3MBTL1KCNA3
SCHEMBL582104 0.68 ELANE (0.46) ELANEPAX8ALDH1A1MAPTL3MBTL1
SCHEMBL2163834 0.67 HDAC1 (0.59) ALDH1A1MAPTKMT2AL3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7728180-B2 Method for producing ethers KURARAY CO., LTD. (JP) 2010-06-01 US disclosed
US-20080262272-A1 Method For Producing Ethers KURARAY CO., LTD. (JP) 2008-10-23 US disclosed
EP-1760061-A1 METHOD FOR PRODUCING ETHERS KURARAY CO., LTD. (JP) 2007-03-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080262272-A1 Method For Producing Ethers TELO2, PDS5A, TERT ELANE 3370/4885PRSS1 4241/4885PRSS2 4155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.